GERN Stock Balance Sheets

Geron Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Inventory

Geron Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2008-09-30	2008-06-30	2007-09-30	2007-06-30	2007-03-31	2006-09-30	2006-06-30	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-03-31	2003-09-30	2003-06-30	2003-03-31	2002-09-30	2002-06-30	2002-03-31

assets
current assets:
cash and cash equivalents	77,734,000	83,745,000	79,016,000	60,344,000	116,945,000	189,761,000	70,023,000	30,709,000	56,903,000	112,777,000	56,845,000	61,103,000	76,057,000	31,325,000	34,871,000	29,036,000	57,282,000	31,537,000	9,925,000	44,956,000	22,865,000	20,294,000	13,644,000	20,751,000	17,710,000	6,800,000	10,575,000	12,729,000	19,127,000	7,912,000	16,335,000	9,904,000	6,606,000	14,861,000	5,883,000	8,199,000	12,802,000	16,823,000	15,798,000	10,182,000	7,600,000	9,520,000	11,324,000	9,591,000	8,834,000	15,505,000	16,008,000	14,123,000	19,031,000	16,105,000	33,975,000	32,019,000	35,412,000	45,972,000	34,490,000	37,315,000	35,900,000	34,601,000	121,807,000	127,080,000	152,767,000	126,943,000	145,722,000	104,556,000	68,875,000	119,303,000	21,609,000	7,530,000	9,846,000	10,185,000	6,529,000	8,042,000	10,956,000	7,089,000	15,428,000	28,245,000	19,609,000
restricted cash	1,870,000	1,865,000	1,860,000	1,854,000	1,123,000	1,119,000	1,115,000	536,000	535,000	365,000	364,000	364,000	364,000	364,000	364,000	363,000	363,000	363,000	363,000	363,000	363,000	270,000	270,000	270,000	270,000	270,000	269,000	269,000	269,000	268,000	268,000	268,000	268,000	268,000	268,000	267,000	267,000	266,000	266,000	266,000	265,000	795,000	795,000	795,000	795,000	794,000	794,000	794,000	793,000	793,000	793,000	793,000	792,000	792,000	792,000	792,000	791,000	791,000	832,000	1,082,000	530,000	530,000	530,000	530,000	530,000	905,000	905,000	530,000	530,000	530,000	530,000	530,000	530,000	530,000	530,000	530,000	530,000
marketable securities	310,247,000	313,132,000	327,550,000	279,430,000	245,789,000	253,288,000	263,676,000	282,818,000	314,475,000	267,964,000	115,901,000	133,684,000	143,230,000	135,345,000	148,851,000	147,084,000	140,959,000	179,490,000	186,350,000	182,667,000	195,881,000	111,822,000	125,681,000	117,860,000	134,778,000	145,180,000	152,714,000	153,622,000	141,800,000	81,868,000	78,351,000	86,991,000	88,239,000	84,432,000	102,655,000	102,402,000	96,846,000	102,857,000	122,214,000	135,655,000				56,617,000	61,966,000	63,534,000													52,537,000	58,571,000	54,875,000	90,011,000	75,504,000	69,493,000	112,276,000	79,536,000	104,525,000	116,955,000	110,118,000	80,015,000	92,673,000
accounts receivable	36,608,000	31,166,000	35,946,000	28,007,000	874,000
interest and other receivables	2,755,000	2,817,000	2,853,000	2,082,000	2,252,000	1,629,000	1,655,000	14,754,000	1,187,000	1,596,000	3,144,000	22,223,000	4,254,000	5,239,000	1,763,000	610,000	714,000	759,000	722,000	989,000	822,000	701,000	802,000	795,000	838,000	976,000	1,168,000	778,000	773,000	569,000	436,000	514,000	457,000	597,000	5,404,000	586,000	624,000	1,238,000	1,505,000	1,190,000	787,000	1,256,000	1,439,000	555,000	480,000	921,000	842,000	932,000	866,000	1,398,000	1,569,000	1,630,000	1,676,000	1,799,000	1,047,000	1,390,000	1,359,000	1,318,000	186,000	305,000	1,105,000	1,259,000	856,000	1,488,000	1,883,000	1,367,000	1,674,000	1,638,000	1,550,000	960,000	5,477,000	681,000	665,000	354,000	1,162,000	803,000	1,016,000
inventory	69,125,000	56,222,000	38,714,000	20,283,000	774,000
prepaid expenses and other current assets	7,256,000	6,822,000		6,057,000	5,551,000
total current assets	505,595,000	495,769,000	490,992,000	398,057,000	373,308,000	451,509,000	341,348,000	335,085,000	377,279,000	387,023,000	180,246,000	222,070,000	227,375,000	175,924,000	187,206,000	179,355,000	201,762,000	215,264,000	199,857,000	231,861,000	220,743,000	134,155,000	141,608,000	142,121,000	154,762,000	155,949,000	166,058,000	168,874,000	162,270,000	91,129,000	95,970,000	98,563,000	102,066,000	106,563,000	115,056,000	111,702,000	110,955,000	122,015,000	140,198,000	147,897,000	128,192,000	142,592,000	147,676,000	68,402,000	72,431,000	81,576,000	103,046,000	120,845,000	122,522,000	125,625,000	147,304,000	157,194,000	170,203,000	195,017,000	137,474,000	130,948,000	133,234,000	117,779,000	179,080,000	192,917,000	212,000	222,631,000	224,955,000	178,141,000	186,374,000	204,030,000	132,172,000	129,477,000	124,777,000	95,128,000	109,366,000
noncurrent marketable securities	42,743,000	58,795,000	94,519,000	37,312,000	66,505,000	20,782,000	43,298,000	67,821,000	28,281,000	28,100,000				10,945,000	28,651,000	39,362,000	40,521,000	33,289,000	63,387,000	45,768,000	46,223,000	1,029,000	19,651,000	20,404,000	9,497,000	17,871,000	18,582,000	18,143,000	20,250,000	13,184,000	14,241,000	15,560,000	22,076,000	22,126,000	21,005,000	25,523,000	31,976,000	31,821,000	18,734,000	17,739,000
property and equipment	1,189,000	1,147,000	1,310,000	1,595,000	1,626,000	1,681,000	1,177,000	1,231,000	1,147,000	1,066,000	793,000	733,000	641,000	643,000	650,000	608,000	590,000	620,000	658,000	689,000	734,000	749,000	408,000	348,000	100,000	89,000	59,000	66,000	71,000	86,000	102,000	121,000	140,000	158,000	170,000	191,000	212,000	183,000	151,000	171,000	63,000	60,000	77,000	116,000	566,000	866,000	1,431,000	1,240,000	1,074,000	1,241,000	2,247,000	2,514,000	2,794,000	3,088,000	3,217,000	3,499,000	3,934,000	3,938,000	4,240,000	4,092,000	3,709,000	3,868,000	3,064,000	2,526,000	2,623,000	2,326,000	2,087,000	1,975,000	2,089,000	2,173,000	1,558,000	1,809,000	1,983,000	2,167,000	2,788,000	3,166,000	3,521,000
operating leases, right-of-use assets	2,523,000	2,704,000	2,881,000	3,055,000	3,225,000	3,392,000	3,556,000	3,683,000	3,841,000	3,995,000	4,147,000	4,296,000	4,442,000	4,586,000	4,727,000	4,892,000	5,029,000	5,163,000	5,295,000	5,425,000	5,492,000	5,827,000	2,497,000
deposits and other assets	3,148,000	4,035,000	4,079,000	4,931,000	4,735,000	4,710,000	4,697,000	5,197,000	4,748,000	4,693,000	5,389,000	5,507,000	5,703,000	6,323,000	4,800,000	4,880,000	4,273,000	4,272,000	1,531,000	2,050,000	1,622,000	1,129,000	1,353,000																		191,000	191,000	191,000	195,000	414,000	410,000	825,000	825,000	879,000	1,048,000	932,000	920,000	230,000	210,000	190,000	284,000	212,000	296,000	1,969,000	702,000	693,000	693,000	594,000	596,000	640,000	520,000	170,000	170,000	175,000	202,000	231,000	227,000	227,000	240,000	254,000	340,000	265,000
liabilities and stockholders' equity
current liabilities:
accounts payable	8,226,000	8,032,000	8,595,000	13,734,000	5,620,000	9,992,000	6,161,000	13,684,000	7,673,000	3,383,000	10,190,000	8,183,000	4,521,000	6,245,000	6,687,000	4,714,000	3,758,000	4,459,000	6,919,000	3,739,000	3,797,000	3,376,000	1,181,000	2,031,000	1,210,000	913,000	982,000	190,000	458,000	502,000	503,000	261,000	205,000	308,000	271,000	235,000	396,000	574,000	957,000	1,180,000	2,365,000	1,223,000	1,520,000	1,547,000	1,176,000	1,669,000	3,014,000	3,429,000	2,666,000	2,980,000	4,006,000	3,471,000	3,343,000	3,462,000	1,958,000	1,715,000	1,807,000	2,176,000	2,108,000	2,443,000	1,990,000	4,118,000	3,342,000	1,435,000	1,572,000	3,067,000	1,848,000	1,388,000	2,535,000	1,667,000	798,000	1,212,000	1,259,000	1,797,000	847,000	861,000	785,000
accrued compensation and benefits	11,336,000	9,603,000	22,808,000	15,180,000	11,382,000	6,794,000	13,759,000	10,837,000	8,232,000	4,906,000	11,534,000	7,637,000	5,613,000	3,682,000	8,099,000	6,615,000	5,216,000	3,446,000	8,218,000	5,554,000	4,204,000	2,674,000	4,830,000	3,443,000	2,756,000	1,661,000	2,642,000	1,833,000	1,531,000	1,100,000	3,385,000	2,651,000	2,056,000	1,489,000	2,205,000	2,311,000	1,619,000	2,248,000	1,731,000	2,135,000	2,685,000	2,186,000	1,556,000	2,886,000	2,046,000	1,664,000	3,907,000	3,421,000	1,774,000	3,029,000
operating lease liabilities	987,000	981,000	974,000	968,000	961,000	955,000	949,000	943,000	786,000	931,000	925,000	919,000	913,000	907,000	901,000	895,000	889,000	883,000	878,000	872,000	856,000	828,000	354,000
liability related to sale of future royalties	17,440,000	15,532,000	20,372,000
accrued liabilities	26,294,000	28,886,000	35,549,000	36,489,000	38,660,000	33,891,000	40,308,000	41,862,000	45,036,000	34,691,000	33,100,000	53,111,000	30,670,000	35,796,000	29,834,000	26,246,000	27,150,000	19,764,000	14,925,000	13,989,000	10,285,000	10,037,000	7,528,000	4,831,000	3,237,000	1,037,000	1,317,000				926,000	1,112,000	856,000	1,054,000	1,432,000	1,126,000	1,071,000	727,000	933,000	1,375,000	2,018,000	1,057,000	1,286,000	1,985,000	1,358,000	2,591,000	4,171,000	4,378,000	4,379,000	3,641,000	3,005,000	3,066,000	3,536,000	2,644,000	1,509,000	1,485,000	1,925,000			2,419,000	3,721,000	3,398,000	2,365,000	1,367,000	1,160,000	1,008,000	862,000	580,000	822,000	677,000	648,000	906,000	1,082,000	905,000	1,762,000	1,529,000	1,434,000
total current liabilities	64,283,000	63,034,000	88,298,000	137,933,000	103,540,000	123,158,000	108,070,000	89,386,000	72,569,000	43,911,000	76,694,000	82,809,000	46,879,000	46,630,000	45,521,000	38,470,000	37,013,000	28,552,000	30,940,000	24,154,000	19,142,000	16,916,000	28,162,000	11,862,000	9,181,000	6,253,000	7,551,000	4,467,000	4,905,000	4,385,000	6,516,000	5,970,000	11,274,000	11,596,000	7,319,000	7,111,000	6,658,000	6,125,000	40,727,000	40,632,000	7,069,000	4,756,000	4,516,000	6,837,000	5,004,000	6,793,000	11,256,000	11,992,000	10,274,000	13,444,000	10,003,000	9,270,000	9,363,000	40,849,000	7,625,000	6,813,000	6,805,000	7,455,000	8,548,000	8,579,000	11,459,000	13,436,000	10,916,000	5,691,000	5,551,000	8,767,000	5,613,000	5,142,000	84,581,852,426,982,000	7,635,000	7,040,000
noncurrent operating lease liabilities	1,865,000	2,069,000	2,266,000	2,458,000	2,645,000	2,829,000	3,006,000	3,179,000	3,498,000	3,512,000	3,671,000	3,826,000	3,977,000	4,125,000	4,267,000	4,405,000	4,540,000	4,672,000	4,799,000	4,922,000	4,991,000	5,159,000	2,200,000
noncurrent liability related to sale of future royalties	110,528,000	110,381,000	104,421,000
noncurrent debt	118,991,000	118,728,000	118,476,000	12,275,000	36,519,000	11,219,000	35,051,000	29,838,000	40,802,000	51,399,000	30,212,000	37,799,000	45,258,000	50,179,000	49,830,000	34,669,000	34,416,000	24,222,000	24,042,000
commitments and contingencies
stockholders' equity:
common stock	638,000	637,000	606,000	603,000	601,000	591,000	545,000	542,000	522,000	509,000	390,000	382,000	378,000	324,000	324,000	321,000	321,000	318,000	310,000	310,000	310,000	200,000	200,000	193,000	187,000	186,000	186,000	186,000	183,000	161,000	160,000	159,000	159,000	159,000	159,000	159,000	159,000	158,000	158,000	158,000	157,000	157,000	157,000	129,000	130,000	130,000	131,000	131,000	132,000		132,000	131,000	129,000		103,000	99,000	97,000		79,000	79,000	75,000	75,000	73,000	66,000	66,000	65,000	55,000	54,000		45,000	45,000	33,000	33,000	25,000	25,000	25,000	24,000
additional paid-in capital	2,067,327,000	2,059,473,000	2,051,794,000	2,037,653,000	2,027,173,000	1,997,709,000	1,844,988,000	1,836,818,000	1,799,841,000	1,777,470,000	1,493,469,000	1,479,417,000	1,472,407,000	1,399,713,000	1,398,006,000	1,390,940,000	1,388,909,000	1,384,262,000	1,366,188,000	1,364,194,000	1,362,373,000	1,217,105,000	1,214,835,000	1,202,902,000	1,192,338,000	1,190,651,000	1,189,194,000	1,187,557,000	1,176,823,000	1,092,931,000	1,089,684,000	1,086,578,000	1,084,440,000	1,082,270,000	1,078,170,000	1,075,922,000	1,073,515,000	1,067,712,000	1,065,352,000	1,062,782,000	1,056,543,000	1,054,383,000	1,052,028,000	945,241,000	943,518,000	942,192,000	938,080,000	936,719,000	935,069,000	932,066,000	928,898,000	925,098,000	920,706,000	881,358,000	783,865,000	775,432,000	767,831,000	750,158,000	668,500,000	664,104,000	633,508,000	628,703,000	619,703,000	573,868,000	572,881,000	560,810,000	481,565,000	476,554,000	458,965,000	418,578,000	414,312,000
accumulated deficit	-1,808,551,000	-1,792,176,000	-1,772,341,000	-1,746,989,000	-1,720,542,000	-1,653,159,000	-1,597,769,000	-1,545,796,000	-1,500,991,000	-1,451,764,000	-1,413,642,000	-1,371,007,000	-1,329,956,000	-1,301,839,000	-1,271,741,000	-1,239,724,000	-1,213,027,000	-1,183,453,000	-1,155,629,000	-1,131,842,000	-1,112,191,000	-1,096,367,000	-1,080,012,000	-1,050,942,000	-1,035,762,000	-1,021,523,000	-1,011,464,000	-1,004,164,000	-998,567,000	-991,633,000	-985,840,000	-978,411,000																	-804,242,000	-785,503,000	-753,649,000	-734,127,000	-713,039,000	-688,650,000	-629,282,000	-610,938,000	-593,907,000	-577,267,000	-489,261,000	-472,110,000	-428,407,000	-415,573,000	-401,588,000	-397,703,000	-387,866,000	-360,703,000	-348,841,000	-345,759,000	-336,071,000	-326,596,000	-307,349,000	-248,110,000	-243,003,000	-233,715,000	-218,554,000	-211,358,000	-202,350,000
accumulated other comprehensive loss	117,000	304,000		1,017,000	-537,000	-273,000	185,000	-950,000	-945,000	-160,000	-219,000	-620,000	-782,000	-711,000													-183,000	-112,000	-77,000	-331,000	-207,000	-52,000																	-46,000	-91,000	-174,000	-42,000	-139,000	-96,000	-16,000	-271,000	-276,000				-37,000	-156,000	-215,000	-318,000	-466,000	-711,000	-731,000	-902,000	-623,000	-716,000	-357,000	-470,000	-475,000	-441,000
total stockholders' equity	259,531,000	268,238,000	280,320,000	292,284,000	306,695,000	344,868,000	247,949,000	290,614,000	298,427,000	326,055,000	79,998,000	108,172,000	142,047,000	97,487,000	126,416,000	151,553,000	176,206,000	201,162,000	210,947,000	232,832,000	250,681,000	120,814,000	135,155,000	152,392,000	157,044,000	169,413,000	177,733,000	183,467,000	178,362,000	101,128,000	103,797,000	108,274,000
debt				71,562,000	46,917,000	71,526,000	46,893,000	22,060,000	10,842,000		20,945,000	12,959,000	5,162,000
prepaid and other current assets			5,053,000			5,712,000	4,879,000	6,268,000	4,179,000	4,321,000	3,992,000	4,696,000	3,470,000	3,651,000	1,357,000	2,262,000	2,444,000	3,115,000	2,497,000	2,886,000	812,000	1,068,000	1,211,000	2,445,000	1,166,000
total liabilities			313,461,000				146,127,000				110,577,000				99,618,000				59,781,000	52,961,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2024 and 2023
accumulated other comprehensive gain			261,000												-173,000	16,000	3,000	35,000	78,000	170,000	189,000	-124,000	132,000	239,000	281,000	99,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2023 and 2022
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2022 and 2021
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2021 and 2020
amount due to janssen biotech, inc.																						1,000	14,269,000	1,208,000	1,576,000	2,071,000	2,610,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2020 and 2019
term loan																				23,885,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2019 and 2018
operating lease, right-of-use asset																								349,000	402,000	571,000
other assets																								1,032,000	1,464,000	1,186,000	585,000	851,000	676,000	1,114,000
operating lease liability																								349,000	402,000	571,000
prepaid assets																										2,723,000	1,332,000	1,476,000	301,000	512,000	580,000	886,000	496,000	405,000	846,000	248,000	416,000	831,000	415,000	604,000	739,000	205,000	249,000	844,000	356,000	822,000	959,000	946,000																		2,784,000	3,320,000	2,681,000		3,371,000	4,090,000	1,389,000	969,000	3,357,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2018 and 2017
accrued collaboration charges																												1,560,000	2,192,000	1,841,000	1,702,000	1,946,000	1,907,000	2,495,000	3,398,000	3,420,000	3,537,000	2,498,000	1,901,000	626,000
other accrued liabilities																												884,000	724,000	942,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at december 31, 2017 and 2016
litigation settlement insurance recovery																																	6,000,000	6,000,000
liabilities and stockholders’ equity
litigation settlement payable																																	6,250,000	6,250,000
stockholders’ equity:
total stockholders’ equity																																	113,008,000	117,251,000	128,912,000	130,305,000	136,485,000	147,894,000	118,356,000	125,175,000	137,178,000	144,583,000	150,892,000	61,876,000	68,407,000	76,059,000	99,772,000	114,201,000	130,913,000	146,603,000	175,207,000	191,060,000	207,657,000	192,735,000	154,670,000	164,322,000	173,745,000	172,577,000	179,250,000	191,964,000	205,139,000	213,049,000	217,973,000	175,913,000	184,340,000	199,314,000	131,868,000	129,740,000	122,063,000	91,171,000	106,454,000
accrued restructuring charges																																			13,000	19,000	35,000	78,000	205,000	316,000			11,000	161,000	374,000	843,000	90,000	734,000	1,417,000	3,730,000
accumulated other comprehensive income																																			25,000	90,000	40,000									18,000	82,000											-406,000	-68,000	-109,000															-590,000	-467,000	-361,000
deferred revenue																																							35,000,000	35,000,000													175,000
fair value of derivatives																																									1,000	290,000	143,000	258,000	50,000	26,000	74,000	30,000	38,000	64,000	137,000	428,000	668,000	707,000	764,000	667,000	839,000	897,000	863,000	701,000	2,533,000	3,502,000	3,711,000
current portion of marketable securities																																									118,801,000	130,816,000	133,869,000				84,443,000	104,050,000	100,394,000	105,208,000	108,127,000	119,756,000	127,915,000	140,599,000	91,056,000	83,789,000	89,390,000	77,009,000
noncurrent portion of marketable securities																																									15,801,000	6,496,000	7,464,000				5,726,000	3,283,000	16,712,000	32,133,000	37,921,000	39,592,000	43,186,000	33,911,000	19,856,000	34,100,000	40,447,000	54,669,000
current portion of prepaid assets																																																	1,438,000	2,121,000	2,840,000	2,996,000	4,408,000	5,855,000	10,089,000	7,662,000	5,794,000	4,060,000	3,718,000	5,879,000	3,070,000	3,888,000	2,343,000	2,074,000	2,810,000				2,586,000
noncurrent portion of prepaid assets																																																				108,000	438,000	854,000	1,364,000	1,867,000	1,966,000	2,372,000	2,567,000	2,897,000	755,000	931,000	226,000	565,000	735,000				3,212,000
investments in licensees																																																				2,000	169,000	504,000	194,000	437,000	932,000	1,328,000
stock issuance obligation																																																						27,500,000
current portion of deferred revenue																																																						350,000	577,000	700,000	700,000	700,000	80,000	134,000	27,000	100,000	605,000	1,455,000	1,737,000	1,862,000	144,000	472,000	477,000	210,000	149,000	307,000	367,000	442,000	567,000	313,000	267,000
preferred stock, 0.001 par value; 3,000,000 shares authorized; no shares
issued and outstanding at december 31, 2011 and 2010
131,443,148 and 122,616,729 shares issued and outstanding at
december 31, 2011 and 2010, respectively																																																		131,000
accrued compensation																																																			2,855,000	2,305,000	1,641,000	6,186,000	2,817,000	2,246,000	1,534,000	1,757,000	2,399,000	1,844,000	1,973,000	1,441,000	893,000	1,434,000	1,082,000	1,276,000	953,000	572,000	2,024,000	1,304,000	478,000	606,000	462,000	329,000	761,000	1,508,000	651,000
long-term debt																																																			3,194,000
noncurrent portion of deferred revenue																																																									175,000	350,000	58,000	65,000	85,000	91,000	98,000	442,000	698,000	1,674,000	458,000	665,000	707,000	751,000	781,000	872,000	923,000	1,002,000	1,063,000	996,000	1,046,000
issued and outstanding at december 31, 2010 and 2009
122,616,729 and 92,521,946 shares issued and outstanding at
december 31, 2010 and 2009, respectively																																																						123,000
accrued liabilities (including amounts for related parties:
2009-none, 2008-270)																																																										1,925,000
current portion of advance payment from related party for research and
development
issued and outstanding at december 31, 2009 and 2008
92,521,946 and 81,070,464 shares issued and outstanding at
december 31, 2009 and 2008, respectively																																																										92,000
2008-267, 2007-1,029)																																																											2,360,000
current portion of advance payment from related party for
research and development																																																											738,000
noncurrent portion of advance payment from related party
for research and development
current portion of advance payment from related party for research and development																																																												1,038,000	1,215,000	877,000
noncurrent portion of advance payment from related party for research and development																																																													921,000	1,657,000
equity investments in licensees																																																													100,000	110,000	148,000			330,000	325,000		489,000	330,000	274,000	427,000	367,000	347,000	314,000
equity investments in licensees and joint ventures																																																																218,000	217,000
intangible assets																																																																		565,000	754,000	942,000	1,131,000	1,671,000	3,103,000	4,535,000	5,251,000	5,967,000	7,400,000	8,116,000	8,832,000
current portion of equipment loans																																																																		82,000	112,000	129,000	146,000	162,000	169,000	189,000	220,000	281,000	528,000	565,000	710,000
current portion of research funding obligation																																																																		1,472,000	1,694,000	2,001,000	2,454,000	3,615,000	4,798,000	4,380,000	4,525,000	4,742,000	4,862,000	4,845,000	4,698,000
commitments
deferred compensation																																																																	-275,000	-147,000	-180,000	-207,000	-260,000	-140,000	-197,000	-131,000	-151,000	-173,000	-53,000	-114,000	-174,000
notes receivable from related parties																																																																		135,000	139,000	143,000	147,000	67,000	67,000	64,000	208,000	366,000	244,000	255,000	265,000
noncurrent portion of equipment loans																																																																				28,000	55,000	82,000	157,000	244,000	285,000	326,000	433,000	620,000	192,000
noncurrent portion of research funding obligation																																																																				295,000	590,000		243,000	1,672,000	2,394,000	3,108,000	4,544,000	5,266,000	5,980,000
equity investments in licensees and joint venture																																																																				484,000
fair value of warrants to purchase common stock
preferred stock, 0.001 par value; 3,000,000 shares
authorized; no shares issued and outstanding
authorized; 52,220,332 shares issued and outstanding																																																																					52,000
convertible debentures																																																																										16,320,000	16,310,000	16,305,000	16,300,000
additional paid-in-capital																																																																								297,279,000	295,739,000	257,563,000	256,006,000	255,374,000	253,649,000
commitments stockholders’ equity:
short-term investments																																																																											31,424,000	33,317,000	48,755,000
other current assets																																																																											2,353,000	638,000	653,000
long-term investments																																																																											6,258,000
equity investment in licensees																																																																												455,000	597,000
redeemable common stock																																																																													1,585,000

We provide you with 20 years of balance sheets for Geron stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Geron. Explore the full financial landscape of Geron stock with our expertly curated balance sheets.

The information provided in this report about Geron stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.